How might PCSK9 inhibition change this debate?

1 September 2014 (19:15 - 19:35)

Organised by:

About the speaker

Doctor Shaun Goodman

St. Michael's Hospital, Toronto (Canada)

5 More presentations in this session

Presentation thumbnail

Introduction - New frontiers in cholesterol management in high CV risk patients.

Professor D. Bhatt (New York City, US)

Presentation thumbnail

How low should LDL-C be lowered? All that matters is how you lower it.

Doctor J. Robinson (Iowa, US)

Presentation thumbnail

How low should LDL-C be lowered? All that matters is how low you lower it.

Professor K. Ray (London, GB)

Presentation thumbnail

Panel discussion - New frontiers in cholesterol management in high CV risk patients.

Presentation thumbnail

Concluding remarks - New frontiers in cholesterol management in high CV risk patients.

Professor J. Zamorano Gomez (Madrid, ES)

Access the full session

Session thumbnail

New frontiers in cholesterol management in high cardiovascular risk patients

The Event

ESC CONGRESS 2014

1 September 2014 19:15 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources